Doctolib

Who owns Doctolib?

Doctolib is currently owned by General Atlantic through General Atlantic Partners (Bermuda) IV, L.P. (2019 vintage), since 2017. Across its history, Doctolib has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

About Doctolib

Doctolib is a Paris-based e-health platform that combines online appointment booking for patients with practice-management software, telehealth, payments and secure messaging for healthcare professionals across France, Germany, Italy and the Netherlands. It is the category leader in France and among Europe's most highly valued healthtech companies, reporting roughly 70 million patient accounts and 340,000 professionals on its core agenda product as of 2023. The company posted annual recurring revenue of EUR 348 million in 2024, up 22.5 percent year on year, and its March 2022 round valued it at EUR 5.8 billion, at the time the highest valuation of any French startup.

Ownership journey

Doctolib was founded in Paris in 2013 by Stanislas Niox-Chateau, Ivan Schneider, Jessy Bernal, Thomas Landais and Steve Abou-Rjeily. Eurazeo entered in November 2017 through its growth strategy, providing roughly half of a EUR 35 million round, invested alongside Bpifrance and earmarked for German expansion. General Atlantic, an investor since 2017, led the EUR 150 million round of March 2019 that lifted Doctolib past a EUR 1 billion valuation. Both sponsors re-invested in the March 2022 round of EUR 500 million in equity and debt, led by Eurazeo with participation from Bpifrance and General Atlantic, at a EUR 5.8 billion valuation. Both positions remain active and no exit has occurred to date.

Under PE ownership

Under its growth investors Doctolib executed a buy-and-build programme: it consolidated the French market by acquiring rival MonDocteur in 2018, entered Italy through the purchase of Dottori.it in October 2021, bought encryption specialist Tanker in January 2022 and added Amsterdam-based medical messaging app Siilo in March 2023, extending the platform into the Netherlands. The sponsor-funded rounds financed the German expansion launched in 2016 and the telehealth service introduced in January 2019, and the 2022 raise underwrote a plan to grow headcount from roughly 2,500 to 6,000 over five years; the company reported about 2,982 employees as of 2023. Commercially, annual recurring revenue reached EUR 348 million in 2024 while losses narrowed 38 percent to EUR 53.8 million, with management guiding to near-term profitability after spending EUR 115 million on research and development in 2024, about a third of revenue.